It says a lot about the expectations of holders that a hazard ratio the same as Herceptin - which has annual sales above 3 times the market cap of IMU - is considered mediocre, DESPITE the fact that HER-Vaxx has lower toxicity and is only one of the company's platforms to boot!
Yes it's not as good as the previous trial, but it's still an excellent, excellent result.
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials
Ann: Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials, page-90
-
-
- There are more pages in this discussion • 256 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.1¢ |
Change
-0.002(3.77%) |
Mkt cap ! $379.2M |
Open | High | Low | Value | Volume |
5.3¢ | 5.3¢ | 5.1¢ | $1.015M | 19.58M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
54 | 7835902 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 11705865 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
53 | 6855510 | 0.051 |
96 | 6675097 | 0.050 |
24 | 3870500 | 0.049 |
18 | 1325211 | 0.048 |
5 | 417000 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 11705865 | 9 |
0.053 | 1323676 | 9 |
0.054 | 599025 | 4 |
0.055 | 2013608 | 13 |
0.056 | 790463 | 9 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |